Volume 3, Issue 2 (6-2013)                   J Research Health 2013, 3(2): 370-378 | Back to browse issues page

XML Print


1- , niknamis@modares.ac.ir
2- دانشگاه علوم پزشکی گناباد، مرکز تحقیقات توسعه اجتماعی و ا رتقای سلامت
Abstract:   (17397 Views)
Diabetes, as the most common disease caused by metabolic disorders, is an important global challenge. This disease needs a lifelong self-care throughout one's life, so this study aimed to determine the effect of health belief model based on educational program on reduction of HbA1c levels in type 2 diabetic females. This study is a quasi-experimental. The samples were 138 diabetic female into two case (n=69)and control groups (n=69).Data was collected via a questionnaire whose validity and reliability had been confirmed. The checklist was according to their reports and tests (HbA1c). Before the educational intervention, the checklist was completed by the two case and control groups. Then, the case samples received required educations in 5 sessions for one month. The educational program consisted of lecture, question and answer, group discussion and film screening. After 3 months, both groups completed the questionnaire and the checklist. The collected data was analyzed by SPSS software and appropriate tests. This study results showed that the mean scores of HBM structures in groups, before and after the educational intervention, have a statistically significant difference. Reduction of HbA1c levels in two studied groups was significant (from 9.63 mg/l before the intervention to 8.30mg/l at 3 months after training). Health belief model based on educational program reduces the HbA1c in diabetic patients. Therefore, training in the framework of this model should be further considered by nurses and health care centers.
Full-Text [PDF 72 kb]   (2936 Downloads)    
Type of Study: Orginal Article |
Received: 2012/05/28 | Accepted: 2013/07/8 | Published: 2013/07/8

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.